Prostate Cell News Volume 16.11 | Jun 20 2025

    0
    45







    2025-06-20 | PCN 16.11


    Prostate Cell News by STEMCELL Technologies
    Vol. 16.11 – 20 June, 2025
    TOP STORY

    Covalent Destabilizing Degrader of AR and AR-V7 in Androgen-Independent Prostate Cancer Cells

    Scientists utilized a cysteine-reactive covalent ligand library in a cellular screen to identify degraders of the androgen receptor (AR) and AR-V7 in androgen-independent prostate cancer cells.
    [Journal of the American Chemical Society]

    AbstractGraphical Abstract
    Scientific resources to support your organoids research. Learn More!
    PUBLICATIONSListed by the impact factor of the journal

    Differentiating Aggressive from Nonaggressive Prostate Cancer Using Unconjugated Contrast Agents

    Investigators systematically explored the cellular uptake of three multimodal contrast agents across prostate cancer cell lines with varying aggressiveness.
    [ACS Applied Materials & Interfaces]

    AbstractGraphical Abstract

    The Additive Value of 68Ga-RM26 PET/CT to 68Ga-PSMA-617 PET/CT in Assessing Post-Treatment Outcomes of ARSIs in mCRPC Patients

    Compared to gastrin-releasing peptide receptor – (GRPR-) patients, metastatic castration-resistant prostate cancer (mCRPC) patients with GRPR + lesions exhibited a lower median maximum PSA response rate and a shorter median progression-free survival duration following ARSI treatment.
    [European Journal of Nuclear Medicine and Molecular Imaging]

    Abstract

    Enhanced Vascular Inflammation in Patients with Advanced Prostate Cancer Receiving Hormone Therapy

    Advanced prostate cancer patients undergoing hormone therapy demonstrate increased arterial inflammation on FDG-PET imaging compared to non-hormonally treated controls.
    [European Journal of Nuclear Medicine and Molecular Imaging]

    Full Article

    D-Mannose Augments Targeted Radioligand-Immunotherapy of Prostate Cancer by Enhancing Radiosensitivity and Reshaping Immune Microenvironment

    Researchers found that oral medication of D-mannose effectively enhances the radiosensitivity of PSMA-positive murine RM1-hPSMA prostate cancer cells to targeted radioligand therapy by suppressing glucose metabolism.
    [Drug Delivery and Translational Research]

    AbstractGraphical Abstract

    Depletion of P2X4 Receptor Alleviates Prostate Cancer Bone Metastasis through Reduced Cancer Cell Invasiveness and Enhanced Cell Adhesion Activities

    To understand the role of P2X4 receptor (P2X4R) in prostate cancer (PCa) biology, particularly in PCa bone metastasis, P2X4R was knocked out in human PCa cell line PC3 cells using the CRISPR/Cas9 system.
    [Purinergic Signalling]

    Full Article
    How to prioritize and manage your research projects
    REVIEWS

    Recent Advances in Drug Treatment for Prostate Cancer

    The authors summarize the latest drug treatment strategies and clinical concerns in the management of advanced prostate cancer in Japan, based on the Japanese Clinical Practice Guidelines for Prostate Cancer published in 2023.
    [Japanese Journal of Radiology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a Novel Radiopharmaceutical Therapeutic, and Diagnostic Agent Targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a Potential Value of up to $1.35bn Plus Royalties

    Philochem AG announced a definitive agreement under which Philochem will license the exclusive worldwide rights to develop, manufacture, and commercialize OncoACP3, a clinical stage therapeutic and diagnostic agent targeting prostate cancer, to RayzeBio.
    [Philochem AG]

    Press Release
    FEATURED EVENT

    Biomaterials and Tissue Engineering

    July 27 – August 1, 2025
    Barcelona, Spain

    > See All Events

    JOB OPPORTUNITIES

    Studentship – Personalization of Prostate Cancer Treatment

    Ulster University – Coleraine, Northern Ireland, United Kingdom

    Research Specialist – Prostate Cancer

    Emory University – Atlanta, Georgia, United States

    Assistant/Associate/Full Professor – Cancer Biology

    Indiana University – Bloomington, Indiana, United States

    MSc Student – Tissue Regeneration and Cancer

    University of Glasgow – Glasgow, Scotland, United Kingdom

    Postdoctoral Fellowship – Prostate Cancer

    Johns Hopkins Medicine – Baltimore, Maryland, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2